- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sudarshan Pharma Industries' 17th Annual General Meeting has concluded, and the Scrutinizer's Report confirms shareholder approval of all proposed resolutions. Shareholders adopted the audited standalone and consolidated financial results for the year ended March 31, 2025. Key approvals also include the re-appointment of Dr. Anil Ghogare as a director, revisions in remuneration for Chairman & Managing Director Mr. Hemal Mehta and Joint Managing Director Mr. Sachin Mehta, and the appointment of a Secretarial Auditor for the next five financial years. This strengthens the company's governance and operational framework.